LKFT Lakefront Biotherapeutics Nv

$34.10 +6.07%

Data as of Nov 4, 2026 close

Healthcare · Pharmaceutical Preparations

Lakefront Biotherapeutics Nv (LKFT) is a healthcare company in the Pharmaceutical Preparations industry. Shares last traded at $34.10.

Market Cap

—

Shares Out

—

EPS (TTM) (per ord. share)

—

P/E (TTM)*

—

P/S Ratio

—

P/B Ratio

—

Dividend / ord. share

—

Dividend Yield

—

52-Week High

—

52-Week Low

—

Volume (venue)

26,678

Avg Vol (3m, venue)

17,908.667

* P/E (TTM) = market cap ÷ net income over the trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year — the same basis as the peer table and the screener, so it can differ from price ÷ EPS.

Lakefront Biotherapeutics Nv reports in EUR: EPS, dividends and financials are shown in EUR as filed, per ordinary share. There is no share count on file for the US listing (a depositary receipt prices at a ratio we do not source), so there is no market cap and no price ratio.

Performance

+6.33%

+16.30%

+30.40%

—

YTD

+18.90%

—

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

77.54

SMA (50)

$29.71

SMA (200)

—

Price vs SMA50

+14.79%

Price vs SMA200

—

ATR (14)

$0.77

Full technical analysis (26 indicators, D/W/M) →

Pharmaceutical Preparations peers

LKFT vs 14 industry peers (Pharmaceutical Preparations), by market cap. Data as of Nov 4, 2026 close

1–14 of 14


LLY	Lilly (Eli)	$1.33T	48.37	15.43	31.9%	+0.62%
JNJ	Johnson & Johnson	$665.2B	41.33	6.70	16.2%	+3.82%
ONC	Beone Medicines Ltd.	$558.0B	850.93	91.04	10.7%	+6.36%
ABBV	AbbVie	$521.3B	50.40	7.90	15.7%	+3.16%
MRK	Merck	$370.7B	151.12	5.50	3.6%	+3.93%
ABT	Abbott Laboratories	$200.2B	42.58	4.15	9.7%	+5.61%
PFE	Pfizer	$175.5B	43.52	2.76	6.3%	+2.70%
VRTX	Vertex Pharmaceuticals	$139.2B	35.01	10.75	30.7%	+3.37%
BMY	Bristol Myers Squibb	$131.2B	14.20	2.62	18.5%	+4.04%
REGN	Regeneron Pharmaceuticals	$96.3B	19.99	5.70	28.5%	-4.41%
TEVA	Teva Pharmaceutical Industries Ltd	$48.8B	96.39	2.83	2.9%	-0.24%
ZTS	Zoetis	$36.8B	14.08	3.87	27.5%	+7.40%
RPRX	Royalty Pharma Plc	$30.1B	44.80	11.50	25.7%	+1.82%
ROIV	Roivant Sciences Ltd.	$27.6B	—	3665.32	—	+5.99%

Source: SEC EDGAR (fundamentals/EPS/dividends, reported in EUR) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.